P

Inventor

BRONSON JOANNE J

US42 patents
⚠️ This page may combine multiple inventors who share the name “BRONSON JOANNE J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

28 patents
US9902722B2Feb 27, 2018

Biaryl kinase inhibitors

BRISTOL MYERS SQUIBB CO19 citations94
US7300936B2Nov 27, 2007

α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors

BRISTOL MYERS SQUIBB CO46 citations94
US5620969AApr 15, 1997

Cephalosporin derviatives

BRISTOL MYERS SQUIBB CO24 citations91
US7786122B2Aug 31, 2010

α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors

BRISTOL MYERS SQUIBB CO12 citations82
US7138423B2Nov 21, 2006

Arylpyrrolidine derivatives as NK-1 /SSRI antagonists

BRISTOL MYERS SQUIBB CO10 citations74
US5559108ASep 24, 1996

Cephalosporin derivatives

BRISTOL MYERS SQUIBB CO13 citations73
US10253027B2Apr 9, 2019

Aryl lactam kinase inhibitors

BRISTOL MYERS SQUIBB CO3 citations72
US9708337B2Jul 18, 2017

Aryl amide-based kinase inhibitors

BRISTOL MYERS SQUIBB CO3 citations72
US5567698AOct 22, 1996

Pyridinium thiomethyl substituted chepholosporin derivatives

BRISTOL MYERS SQUIBB CO7 citations72
US5436369AJul 25, 1995

Alicyclic phospholipase A2 inhibitors

BRISTOL MYERS SQUIBB CO9 citations71
US10544120B2Jan 28, 2020

Biaryl kinase inhibitors

BRISTOL MYERS SQUIBB CO2 citations62
US10246469B2Apr 2, 2019

Biaryl kinase inhibitors

BRISTOL MYERS SQUIBB CO1 citations62
US7022667B2Apr 4, 2006

O-derivatized nocathiacin derivatives

BRISTOL MYERS SQUIBB CO5 citations62
US8026257B2Sep 27, 2011

Substituted heterocyclic ethers and their use in CNS disorders

BRISTOL MYERS SQUIBB CO4 citations61
US5668284ASep 16, 1997

Cephalosporin derivatives

BRISTOL MYERS SQUIBB CO1 citations61
US9932320B2Apr 3, 2018

Quinoline-based kinase inhibitors

BRISTOL MYERS SQUIBB CO1 citations51
US9738642B2Aug 22, 2017

Triazolopyridine ether derivatives and their use in neurological and pyschiatric disorders

BRISTOL MYERS SQUIBB CO1 citations51
US8969564B2Mar 3, 2015

Aryl ether-base kinase inhibitors

BRISTOL MYERS SQUIBB CO0 citations51
US8901305B2Dec 2, 2014

Aryl lactam kinase inhibitors

BRISTOL MYERS SQUIBB CO1 citations51
US8703953B2Apr 22, 2014

Aryl ether-base kinase inhibitors

BRISTOL MYERS SQUIBB CO1 citations51
US8372847B2Feb 12, 2013

Pyrazinone modulator of corticotropin-releasing factor receptor activity

BRISTOL MYERS SQUIBB CO0 citations51
US7932256B2Apr 26, 2011

(S)-4-(1-cyclopropyl-2-methoxyethyl)-6-(6-(difluoromethoxy)-2,5-dimethylpyridin-3-ylamino)-5-oxo-4,5-dihydropyrazine-2-carbonitrile: a pyrazinone modulator of corticotropin-releasing factor receptor activity

BRISTOL MYERS SQUIBB CO0 citations51
US5668290ASep 16, 1997

Substituted 4-thio pyridones

BRISTOL MYERS SQUIBB CO1 citations51
US9688669B2Jun 27, 2017

Oxazolidinones as modulators of mGluR5

BRISTOL MYERS SQUIBB CO1 citations49
US10035777B2Jul 31, 2018

Heterocyclic kinase inhibitors

BRISTOL MYERS SQUIBB CO0 citations41
US9737542B2Aug 22, 2017

Pyrrolotriazine kinase inhibitors

BRISTOL MYERS SQUIBB CO0 citations41
US7632861B2Dec 15, 2009

Substituted heterocyclic ethers and their use in CNS disorders

BRISTOL MYERS SQUIBB CO0 citations40
US10174044B2Jan 8, 2019

Fused pyridines as kinase inhibitors

BRISTOL MYERS SQUIBB CO0 citations37

ACAD OF SCIENCE CZECH REPUBLIC

7 patents

PARKER MICHAEL F

2 patents

BI YINGZHI

2 patents

BRISTOL MEYERS SQUIBB CO

1 patent

BRISTOL MYERS SQUIBB

1 patent

DZIERBA CAROLYN DIANE

1 patent